BRIEF-Pediapharm announces global exclusive licensing agreement for Relaxa(R)

* Pediapharm announces global exclusive licensing agreement for Relaxa(R), an established Canadian product with existing revenues
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.